版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
演講人:日期:免疫治療科普英文IntroductiontoImmunotherapyHowDoesImmunotherapyWork?BenefitsandRisksofImmunityLatestResearchandDevelopmentsinImmunotherapyAccessingandAffordabilityTreatments目錄01IntroductiontoImmunotherapyImmunotherapyisatypeofcancertreatmentthatusesthebody'sownimmunesystemtofitcancercellsItworksbystimulatingorrestoringtheimmunesystem'sabilitytorecognizeandattachcancercellsImmunotherapycanbeusedaloneorincombinationwithothercancertreatments,suchassurgery,chemotherapy,orradiationtherapyWhatisImmunotherapy?Earlyformsofhomologydatebacktothelate19thcenturywhendoctorsbeginusingbacteriaortoxinstostimulatetheimmunesystemInthe1970s,researchersdiscoveredthattheimmunesystemcouldbetrainedtorecognizeandattachcancercellsOverthepastdecade,therehasbeenasurgeinthedevelopmentofnewessentialdrugsandtechnologies,leadingtoimprovedoutcomesformanypatientsHistoryandDevelopmentofImmunotherapyThisisthebody'sfirstlineofdefenseagainstforeigninvaders,includingbacteria,viruses,andcancercellsItincludesphysicalbarriers(suchasskinandmucousmembranes)andchemicalbarriers(suchasacidsandenzymes)InnateImmunityThisisthebody'smorespecificandlonglastimmuneresponseItinvolvestheproductionofantibioticsandtheactivationofT-cellstotargetanddestroyspecificinvaders,includingcancercellsAdaptiveImmunityTypesofImmunities
WhoCanBenefitfromImmunotherapy?Patientswithcancertypesofcancer,suchasmalaria,lungcancer,andbladdercancer,maybenefitfromimmunotherapyImmunotherapymaybesignificantlyeffectiveforpatientswhohaverecurrentorspreaddespiteothertreatmentsSomepatientsmaybeeligibleforimmunotherapyaspartofaclinicaltrialtotestnewbugsorcombinationsoftreatments02HowDoesImmunotherapyWork?Immunotherapystimulatesthebody'sownimmunesystemtorecognizeandattachcancercellsImmunecheckpointinhibitorsarebugsthatblockcancerproteinsoncancercells,allowingtheimmunesystemtoidentifyanddestroythemCytokinesareproteinsthatstimulatetheimmunesystemandcanbeusedtoenhancethebody'sresponsetocancerSimulatingtheImmuneSystemMonoclonalantibioticsarelaboratoryproducedmoldsthatattachtospecifictargetsoncancercellsSpecificantibioticscansimilarlyattachtotwodifferentantibiotics,eitheronthesameordifferentcancercells,enhancingtheimmuneresponseAntibodydrugconnections(ADCs)areantibioticslinkedtocancerkillingdrugs,deliveringthemedicinedirectlytothetuitionsiteTargetingCancerCellswithAntibodies01ACTinvolvescollectingandusingpatients'ownimmunecells,whichhavebeenmodifiedtoattackcancercells02T-celltherapy,atypeofACT,involvingisolationandmultiplyingapatient'sT-cellsinthelaboratorybeforereintroducingthemintothebodytofitcancer03CART-celltherapyisaspecializedtypeofT-celltherapywheretheT-cellsaregeneticallymodifiedtoproducechiralantigenreceptors(CARs)thattargetspecificantigensoncancercellsAdaptiveCellTransfer(ACT)TherapeuticcancervaccinesstimulatetheimmunesystemtoattackspecificcancercellsPersonalizedvaccinesarecreatedusingapatient'sowntuberantstoelicitamoretargetedimmuneresponse單擊此處添加正文,文字是您思想的為了最終呈現(xiàn)發(fā)布的。單擊此處添加正文文字是您思。文字是您思。單擊此處添加正文文字是您思。文字是您思。4行*21字Dendriticcellvaccinesuseapatient'sowndendriticcells,whichareloadedwithcancerantigensandthenreintroducedintothebodytostimulateanimmuneresponseVaccinesforCancerTreatment03BenefitsandRisksofImmunityEnhancedimmuneresponseImmunotherapycanstimulatethebody'sownimmunesystemtorecognizeandattachcancercellsmoreeffectivelyTargetedtreatmentUnlikechemotherapy,whichaffectsbothhealthandcancercells,negligibletargetsspecificproteinsormarkersoncancercells,leavinghealthcellslargeunharmedDurableresponseInsomecases,negligiblecanprovidelongtermremittanceorevenacure,astheimmunesystemcontinuestofitthecancerevenaftertreatmenthasendedPotentialBenefitsofImmunoherapyInflammationandautoimmunereactionsImmunotherapycanstimulatesomeemotionswithanoveractiveimmuneresponse,leadingtoinflationorautoimmunediseasesAllergicreactionsSomeimmunotherapydrugscancauseAllergicreactions,rangingfrommilltosevereInfectionriskBecausetheimmunesystem,itcanincreasetheriskofinfectionCommonSideEffectsandRisksMedicalmanagementPrescriptiontreatmentscanbeusedtotreatinflammation,pain,andothersideeffectsLifestylemodificationsChangesindie,exercise,andsleephabitscanhelpreducetheseverityofsideeffectsandimproveoverallhealthClosemonitoringRegularcheckupsandbloodtestscanhelpidentifyandmanagesideeffectsearlyManagingSideEffectswithSupportingCareContinuousmonitoringEvenaftertreatmenthasended,regularcheckupsandmonitoringareimportanttoensurethatthecancerhasnotbeenreturnedPotentialforlongtermremovalInsomecases,negligiblecanprovidelongtermremovalorevenacureOngoingresearchanddevelopmentImmunotherapyisarapidlydevelopingfield,andnewtreatmentsandcombinationsoftreatmentsarecontinuouslybeingstudiedandtestedLongTermOutlookafterImmunotherapy04LatestResearchandDevelopmentsinImmunotherapyCombinationofImmunoherapyandChemotherapyCombiningimmunoherapybugswithchemotherapyhasshownpromiseresultsinshrinkingtubersandprolongingsurvivalinsomecancerpatientsImmunotherapyandRadiationTherapyRadiationtherapycanenhancetheeffectsofimmunitybyreleasingtumorantigensandstimulatingtheimmunesystemtoattackcancercellsTargetedTherapyandImmunotherapyTargetedtherapydrugsthatspecificallytargetcancercellsincancercellscanbecombinedwithimmunotherapytoachievebettertreatmentoutcomesCombinationTherapywithOtherTreatmentsGeneticTestingforPersonalizedTreatmentGenetictestingofstudentscanhelpidentifyspecificmutationsthatcanbetargetedbyimmunotherapydrugs,enablingpersonalizedtreatmentplansBiomerkerDrivenClinicalTrialsClinicaltrialsareincreasinglyfocusingonbiomarkerdrivenpatientselectiontoensurethattherightpatientsreceivethemosteffectiveimmunotherapytreatmentsDevelopmentofPersonalizedVacanciesPersonalizedVacanciesarebeingdevelopedthatstimulatestheimmunesystemtoattackspecifictuberantsuniquetoeachpatient'scancerPersonalizedMedicineandPrecisionImmunotherapy010203ImmuneCheckpointInhibitorsImmuneCheckpointInhibitorsareatypeofimmunitydrugthatblockscontainproteinsonimmunecells,allowingthemtoattackcancercellsmoreeffectivelyT-CellEngagingTherapyT-cellengagingtherapiesinvolvetheuseofengineeredT-cellsorantibioticsthatdirectT-cellstoattackcancercellsTumorInfiltratingLymphocytes(TILs)TILsareatypeofimmunecellfoundwithintutorsthatcanbeisolated,expanded,andreinfusedintopatientstoattacktheircancerNewTargetsforCancerImmunotherapyDevelopmentofMoreEffectandLessToxicImmunoherapyDrugsOngoingresearchisfocusedondevelopingnewimmunoherapydrugsthataremoreeffectiveandhavefeltsideeffectsthatarecurrenttreatmentsCombinationofImmunotherapywithOtherEmergingTechnologiesImmunotherapyisbeingcombinedwithotheremergingtechnologies,suchasgeneeditingandcelltherapy,tocreatemorepowerfulandtargetedtreatmentsforcancerUnderstandingtheRoleoftheMicrobiomeinImmunotherapyResponseResearchisalsoexploringtheroleofthemicrobiome(thecollectionofmicroorganismsinthebody)indeterminingapatient'sresponsetoimmunotherapytreatmentsFutureDirectionsinResearch05AccessingandAffordabilityTreatmentsSearchingOnlineDatabasesUtilizeonlineclinicaltrialdatabasesortreatmentcenterdirectoriestofindimmunodeficiencyoptionsConsultingwithHealthcareProvidersDiscussionswithyourhealthcareprovideraboutpotentialclinicaltrialsortreatmentcentersAttendingMedicalConferencesMedicalconferencesoftenprovideinformationaboutthelatestessentialresearchandtreatmentoptionsFindingClinicalTrialsorTreatmentCentersCostVariesbyTreatmentType01Thecostofnegligiblecanvarywidelydependingonthetypeoftreatment,suchasmonoclonalantibiotics,cancervaccines,orcellbasedtherapiesInsuranceCoverage02CheckwithyourinsuranceprovidertounderstandwhatessentialtreatmentsarecoveredandwhatoutofpocketcostsmaybeinvolvedCostBenefitAnalysis03ConsiderthepotentialbenefitsofimmunotherapyinrelationtoitscostUnderstandingtheCostofImmunotherapyPharmaceuticalCompanyProgramsManypharmaceutica
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 環(huán)境經(jīng)濟(jì)學(xué)試題庫(kù)(含參考答案)
- 護(hù)理教育導(dǎo)論模擬練習(xí)題含答案
- 保安跨省派遣合同范例
- 2025年喀什貨運(yùn)上崗證考試題
- 個(gè)人占地協(xié)議合同范例
- 公路汽車租賃合同范例
- 活動(dòng)方式合同范例
- 2025年杭州貨運(yùn)從業(yè)資格證考試模擬題庫(kù)
- 天府新區(qū)航空旅游職業(yè)學(xué)院《審計(jì)學(xué)2(注會(huì))》2023-2024學(xué)年第一學(xué)期期末試卷
- 2025年泰安駕駛資格證模擬考試
- 中醫(yī)科進(jìn)修總結(jié)匯報(bào)
- 初中英語比較級(jí)和最高級(jí)專項(xiàng)練習(xí)題含答案
- 激光技術(shù)在能源、環(huán)保、農(nóng)業(yè)等領(lǐng)域的應(yīng)用
- 【高分復(fù)習(xí)筆記】周小普《廣播電視概論》筆記和課后習(xí)題詳解
- 中國(guó)玉石及玉文化鑒賞智慧樹知到期末考試答案2024年
- MOOC 物理與藝術(shù)-南京航空航天大學(xué) 中國(guó)大學(xué)慕課答案
- 《旅游財(cái)務(wù)管理》課件-1認(rèn)識(shí)旅游企業(yè)
- (正式版)JBT 5300-2024 工業(yè)用閥門材料 選用指南
- 工藝工程師的成長(zhǎng)計(jì)劃書
- 家政運(yùn)營(yíng)方案
- 會(huì)展英語教學(xué)大綱
評(píng)論
0/150
提交評(píng)論